Protagenic Therapeutics, Inc. (PTIX)
0.4174
0.00 (0.00%)
USD |
OTCM |
Nov 19, 16:00
Protagenic Therapeutics Gross Profit (TTM) : -0.0353M for Sept. 30, 2026
Gross Profit (TTM) Chart
Historical Gross Profit (TTM) Data
| Date | Value |
|---|---|
| September 30, 2026 | -0.0353M |
| June 30, 2026 | -0.045M |
| March 31, 2026 | -0.0492M |
| December 31, 2025 | -0.0503M |
| September 30, 2025 | -0.0503M |
| June 30, 2025 | -0.0503M |
| March 31, 2025 | -0.0503M |
| December 31, 2024 | -0.0503M |
| September 30, 2024 | -0.0643M |
| June 30, 2024 | -0.0532M |
| March 31, 2024 | -0.0407M |
| December 31, 2023 | -0.0282M |
| September 30, 2023 | -0.0016M |
| June 30, 2023 | -0.0002M |
| March 31, 2023 | -0.0001M |
| December 31, 2022 | 0.00 |
| September 30, 2022 | 0.00 |
| June 30, 2022 | 0.00 |
| March 31, 2022 | 0.00 |
| December 31, 2021 | 0.00 |
| September 30, 2021 | 0.00 |
| June 30, 2021 | -0.0001M |
| March 31, 2021 | -0.0002M |
| December 31, 2020 | -0.0003M |
| September 30, 2020 | -0.0003M |
| Date | Value |
|---|---|
| June 30, 2020 | -0.0003M |
| March 31, 2020 | -0.0003M |
| December 31, 2019 | -0.0003M |
| September 30, 2019 | -0.0003M |
| June 30, 2019 | -0.0003M |
| March 31, 2019 | -0.0003M |
| December 31, 2018 | -0.0003M |
| September 30, 2018 | -0.0003M |
| June 30, 2018 | -0.0003M |
| March 31, 2018 | -0.0003M |
| December 31, 2017 | -0.0011M |
| September 30, 2017 | -0.0012M |
| June 30, 2017 | -0.0012M |
| March 31, 2017 | -0.0014M |
| December 31, 2016 | -0.0005M |
| September 30, 2016 | -0.0004M |
| June 30, 2016 | -0.0002M |
| March 31, 2016 | -0.0001M |
| June 30, 2015 | 0.888M |
| March 31, 2015 | 1.717M |
| December 31, 2014 | 2.682M |
| September 30, 2011 | -1.032M |
| June 30, 2011 | 2.343M |
| March 31, 2011 | 5.994M |
| December 31, 2010 | 9.562M |
Gross Profit Definition
Annual, Interim and Preliminary Items - Commercial, Other Financial Companies
Gross Profit (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit (TTM) Benchmarks
| Oncolytics Biotech, Inc. | -0.048M |
| Sangamo Therapeutics, Inc. | 28.00M |
| Sarepta Therapeutics, Inc. | 1.074B |
| Anixa Biosciences, Inc. | -0.039M |
| Vicapsys Life Sciences, Inc. | 0.00 |